Cargando…

Defining a conformational ensemble that directs activation of PPARγ

The nuclear receptor ligand-binding domain (LBD) is a highly dynamic entity. Crystal structures have defined multiple low-energy LBD structural conformations of the activation function-2 (AF-2) co-regulator-binding surface, yet it remains unclear how ligand binding influences the number and populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Chrisman, Ian M., Nemetchek, Michelle D., de Vera, Ian Mitchelle S., Shang, Jinsai, Heidari, Zahra, Long, Yanan, Reyes-Caballero, Hermes, Galindo-Murillo, Rodrigo, Cheatham, Thomas E., Blayo, Anne-Laure, Shin, Youseung, Fuhrmann, Jakob, Griffin, Patrick R., Kamenecka, Theodore M., Kojetin, Douglas J., Hughes, Travis S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935666/
https://www.ncbi.nlm.nih.gov/pubmed/29728618
http://dx.doi.org/10.1038/s41467-018-04176-x
Descripción
Sumario:The nuclear receptor ligand-binding domain (LBD) is a highly dynamic entity. Crystal structures have defined multiple low-energy LBD structural conformations of the activation function-2 (AF-2) co-regulator-binding surface, yet it remains unclear how ligand binding influences the number and population of conformations within the AF-2 structural ensemble. Here, we present a nuclear receptor co-regulator-binding surface structural ensemble in solution, viewed through the lens of fluorine-19 ((19)F) nuclear magnetic resonance (NMR) and molecular simulations, and the response of this ensemble to ligands, co-regulator peptides and heterodimerization. We correlate the composition of this ensemble with function in peroxisome proliferator-activated receptor-γ (PPARγ) utilizing ligands of diverse efficacy in co-regulator recruitment. While the co-regulator surface of apo PPARγ and partial-agonist-bound PPARγ is characterized by multiple thermodynamically accessible conformations, the full and inverse-agonist-bound PPARγ co-regulator surface is restricted to a few conformations which favor coactivator or corepressor binding, respectively.